BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Dr. Lal PathLabs Ltd
sales of 9.12 billion Indian Rupees [US$140.87 million]
Falco Holdings Co Ltd
(45.97 billion Japanese Yen [US$412.36 million]
Miraca Holdings Incorporated
(204.25 billion Japanese Yen [US$1.83 billion]
BML Inc reported sales of ¥111.24 billion (US$997.85 million)
March of 2017.
increase of 2.0%
versus 2016, when the company's sales were ¥109.02 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2012, sales have increased a total of 21%).